Pharmaceuticals & Drugs
We are a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Our strength lies in identifying, developing and manufacturing a diverse range of specialty, underpenetrated and complex pharmaceutical products establishing us as a preferred partner to certain customers. Through data analytics, research, market assessment and experienced management, we strategically identify commercially underpenetrated molecules to launch products in the Regulated and Emerging Markets. We leverage our R&D capabilities to develop and manufacture a portfolio of differentiated complex pharmaceutical products. Our focus on quality and our ability to identify specialty and complex molecules has resulted in an extensive pipeline of curated complex products spanning diverse dosage forms and therapeutic domains, demonstrated through our partnerships in the Regulated Markets with prominent foreign and Indian pharmaceutical companies including Prasco LLC, Lannett Company Inc., Jubilant Cadista Pharmaceuticals Inc., Alkem Laboratories Limited, Sun Pharmaceuticals Industries Limited, Dr. Reddy’s Laboratories Inc. and Cipla USA Inc.
4. Project Name: Investment in one of our Subsidiaries, Havix, to fund capital expenditure requirements for setting u
Project Cost: 1070
5. Project Name: Re-payment/pre-payment, in full or in part, of certain borrowings availed by our Company
Project Cost: 734.8
6. Project Name: Investment in our Subsidiary, namely, Havix, for re- payment/pre-payment in full or in part, of cert
Project Cost: 202.2
7. Project Name: Funding the working capital requirements of our Company
Project Cost: 432.59
8. Project Name: Investment in our Subsidiaries, namely, SPI and Ratnatris to fund their working capital requirements
Project Cost: 594.83
9. Project Name: Funding inorganic growth through acquisition and other strategic initiatives
Project Cost: 1543.68
1. Swapnil Jatinbhai Shah
2. Ashokkumar Vijaysinh Barot
Data not availble
Field Description | Field Value |
---|---|
Ipo Code | 3028 |
Total Equity | 8534681 |
Field Description | Field Value |
---|---|
No of Shares Offered/Reserved For Qualified Institutional Buyers | 4593216 |
No of Shares Bid For Qualified Institutional Buyers | 434778102 |
Total No of Shares Bid For Qualified Institutional Buyers | 94.66 |
No of Shares Offered/Reserved For Foreign Institutional Buyers | 0 |
No of Shares Bid For Foreign Institutional Buyers | 90129996 |
Total No of Shares Bid For Foreign Institutional Buyers | 0.00 |
No of Shares Offered/Reserved For Mutual Fund | 0 |
No of Shares Bid For Mutual Fund | 7309680 |
Total No of Shares Bid For Mutual Fund | 0.00 |
No of Shares Offered/Reserved For Qualified Institutional Buyers - Others | 0 |
No of Shares Bid For Qualified Institutional Buyers - Others | 337338426 |
Total No of Shares Bid For Qualified Institutional Buyers - Others | 0.00 |
Field Description | Field Value |
---|---|
No of Shares Offered/Reserved For Non-Institutional Buyers | 2319879 |
No of Shares Bid For Non-Institutional Buyers | 222963632 |
Total No of Shares Bid For Non-Institutional Buyers | 96.11 |
No of Shares Offered/Reserved For Corporate | 0 |
No of Shares Bid For Corporate | 7303144 |
Total No of Shares Bid For Corporate | 0.00 |
No of Shares Offered/Reserved For Individuals | 0 |
No of Shares Bid For Individuals | 205914134 |
Total No of Shares Bid For Individuals | 0.00 |
No of Shares Offered/Reserved For Individuals - Others | 0 |
No of Shares Bid For Individual Others | 9746354 |
Total No of Shares Bid For Individual Others | 0.00 |
Field Description | Field Value |
---|---|
No of Shares Offered/Reserved For Retail Individual Investor | 1546586 |
No of Shares Bid For Retail Individual Investor | 137996278 |
Total No of Shares Bid For Retail Individual Investor | 89.23 |
No of Shares Offered/Reserved For Retail Individual Investor - Cutoff | 0 |
No of Shares Bid For Retail Individual Investor - Cutoff | 124934690 |
Total No of Shares Bid For Retail Individual Investor - Cutoff | 0.00 |
No of Shares Offered/Reserved For Retail Individual Investor | 0 |
No of Shares Bid For Retail Individual Investor | 13061588 |
Total No of Shares Bid For Retail Individual Investor | 0.00 |
Field Description | Field Value |
---|---|
No of Shares Offered/Reserved For Employee | 75000 |
No of Shares Bid For Employee | 1494122 |
Total No of Shares Bid For Employee | 19.92 |
No of Shares Offered/Reserved Employee - Cutoff | 0 |
No of Shares Bid For Employee - Cutoff | 1362566 |
Total No of Shares Bid For Employee - Cutoff | 0.00 |
Total No of Shares Bid Offered/Reserved For Employee | 0 |
No of Shares Bid Offered/Reserved For Employee | 131556 |
Total No of Shares Bid For Employee | 0.00 |
Field Description | Field Value |
---|---|
No of Shares Offered/Reserved For All | 8534681 |
No of Shares Bid For All | 797232134 |
Total | 93.41 |